Does TACROLIMUS SYSTEMIC Cause Off label use? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Off label use have been filed in association with TACROLIMUS SYSTEMIC. This represents 25.5% of all adverse event reports for TACROLIMUS SYSTEMIC.
12
Reports of Off label use with TACROLIMUS SYSTEMIC
25.5%
of all TACROLIMUS SYSTEMIC reports
4
Deaths
0
Hospitalizations
How Dangerous Is Off label use From TACROLIMUS SYSTEMIC?
Of the 12 reports, 4 (33.3%) resulted in death.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS SYSTEMIC. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS SYSTEMIC Cause?
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)